Phio Pharmaceuticals Corp (RXII) - Financial and Strategic SWOT Analysis Review



Phio Pharmaceuticals Corp (Phio Pharmaceuticals), formerly known as RXi Pharmaceuticals Corp, is a biotechnology company. It discovers, develops and commercializes immuno-oncology therapeutics based RNAi platform to treat cancer. Its product pipeline includes PH-762, PH-894 and PH-804 for adoptive cell therapy, tumor microenvironment and intratumoral. Phio Pharmaceuticals also provides clinical trial services. It offers products for the treatment of anti scarring, macular degeneration, retinoblastoma, and liver diseases. The company partners with academia, biotech, and large multi-national organizations for the development of new therapeutics. Phio Pharmaceuticals is headquartered in Marlborough, Massachusetts, the US.

Phio Pharmaceuticals Corp Key Recent Developments

Aug 12,2020: Phio Pharmaceuticals reports second quarter 2020 financial results and provides business update
Jun 08,2020: Phio Pharmaceuticals to Host Key Opinion Leader Call on Intratumoral Therapy with Self-Delivering RNAi on Friday, June 12th
May 29,2020: Phio announces positive in vivo data on the intratumoral use of INTASYL compounds showing strong antitumor activity
May 14,2020: Phio presents data on INTASYL as an alternative to genetic modification to improve cell-based immunotherapy at ASGCT 2020
May 12,2020: Phio Pharmaceuticals reports first quarter 2020 financial results and provides business update

This comprehensive SWOT profile of Phio Pharmaceuticals Corp provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of Profile on Demand service, covering over 50,000 of the worlds leading companies. Once purchased, highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Phio Pharmaceuticals Corp including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.


Section 1 - About the Company

Phio Pharmaceuticals Corp - Key Information
Phio Pharmaceuticals Corp - Overview
Phio Pharmaceuticals Corp - Key Employees
Phio Pharmaceuticals Corp - Key Employee Biographies
Phio Pharmaceuticals Corp - Key Operational Heads
Phio Pharmaceuticals Corp - Major Products and Services
Phio Pharmaceuticals Corp - History
Phio Pharmaceuticals Corp - Company Statement
Phio Pharmaceuticals Corp - Locations And Subsidiaries
Phio Pharmaceuticals Corp
Head Office
Other Locations & Subsidiaries

Section 2 - Company Analysis

Phio Pharmaceuticals Corp - Business Description
Phio Pharmaceuticals Corp - Corporate Strategy
Phio Pharmaceuticals Corp - SWOT Analysis
SWOT Analysis - Overview
Phio Pharmaceuticals Corp - Strengths
Phio Pharmaceuticals Corp - Weaknesses
Phio Pharmaceuticals Corp - Opportunities
Phio Pharmaceuticals Corp - Threats
Phio Pharmaceuticals Corp - Key Competitors

Section 3 - Company Financial Performance Charts

Phio Pharmaceuticals Corp - Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

Section 4 - Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer


Note*: Some sections may be missing if data is unavailable for the company

List Of Tables



Phio Pharmaceuticals Corp, Key Information
Phio Pharmaceuticals Corp, Key Ratios
Phio Pharmaceuticals Corp, Share Data
Phio Pharmaceuticals Corp, Major Products and Services
Phio Pharmaceuticals Corp, History
Phio Pharmaceuticals Corp, Key Employees
Phio Pharmaceuticals Corp, Key Employee Biographies
Phio Pharmaceuticals Corp, Key Operational Heads
Phio Pharmaceuticals Corp, Other Locations
Phio Pharmaceuticals Corp, Subsidiaries
Phio Pharmaceuticals Corp, Key Competitors
Phio Pharmaceuticals Corp, SWOT Analysis
Phio Pharmaceuticals Corp, Ratios based on current share price
Phio Pharmaceuticals Corp, Annual Ratios
Phio Pharmaceuticals Corp, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures



Phio Pharmaceuticals Corp, Performance Chart
Phio Pharmaceuticals Corp, Ratio Charts

Sophion Bioscience AS - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Sophion Bioscience A/S (Sophion Bioscience), a subsidiary of Biolin Scientific AB is a medical device company that offers specialized products and integrated solutions for automated patch clamping. The company develops

USD 250 View Report

Aphios Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile.

Aphios Corp (Aphios) is a biotechnology company that develops nanotechnology drug delivery platforms. The company provides technology platforms and enhanced therapeutics for the treatment of infectious diseases, cancers and central

USD 250 View Report

Acerus Pharmaceuticals Corp (ASP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile.

Acerus Pharmaceuticals Corp (Acerus), formerly Trimel Pharmaceuticals Corporation, is a pharmaceutical company that develops, manufactures, markets and distributes innovative branded products. It focuses on mens and womens health. The company

USD 250 View Report

Adamis Pharmaceuticals Corp (ADMP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile.

Adamis Pharmaceuticals Corp (Adamis), formerly Cellegy Pharmaceuticals Inc is a biopharmaceutical company that offers therapies. The company develops and commercializes products in the therapeutic areas of allergy and respiratory diseases.

USD 250 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available